• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭住院后简单心脏合并症计数与心血管再入院的关系。

Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization.

机构信息

Rutgers New Jersey Medical School, Newark, New Jersey.

Department of Medicine, Weill Cornell Medicine, New York, New York.

出版信息

Am J Cardiol. 2020 May 15;125(10):1529-1535. doi: 10.1016/j.amjcard.2020.02.018. Epub 2020 Mar 5.

DOI:10.1016/j.amjcard.2020.02.018
PMID:32245637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8819501/
Abstract

Although several risk calculators are available to determine risk for readmission following a heart failure (HF) hospitalization, none provide information on cause-specific readmission. Understanding risk for cause-specific readmission could aid in developing a targeted approach to reducing readmissions. We sought to determine if a simple cardiac co-morbidity count could identify individuals at high risk for a cardiovascular (CV) readmission following a HF hospitalization. Using the Nationwide Readmissions Database, we examined nonfatal hospital discharges with a principal diagnosis of HF. We calculated a 0 to 3 cardiac co-morbidity count based on the presence of coronary artery disease, atrial arrhythmia, and/or ventricular arrhythmia. We used a multinomial logistic regression to determine if the cardiac co-morbidity count was independently associated with CV readmission or non-CV readmission, adjusting for patient- and hospital-level confounders. In 380,075 discharges, 28% had a co-morbidity count of 0, 47% had a count of 1, 23% had a count of 2, and 2% had a count of 3. In a fully adjusted model, cardiac co-morbidity count was independently associated with CV readmission: compared with individuals with a count of 0, the relative risk for those with a count of 1 was 1.27 (95% confidence interval [CI]: 1.23 to 1.31); for those with a count of 2 was 1.40 (95% CI: 1.35 to 1.46); and for those with a count of 3 was 1.36 (95% CI: 1.23 to 1.51). Cardiac co-morbidity count was not independently associated with non-CV readmission. In conclusion, we found that a simple cardiac co-morbidity count was independently associated with increased risk of CV but not non-CV readmission.

摘要

虽然有几种风险计算器可用于确定心力衰竭 (HF) 住院后的再入院风险,但没有一种提供与特定原因再入院相关的信息。了解特定原因再入院的风险有助于制定针对减少再入院的目标方法。我们试图确定简单的心脏合并症计数是否可以识别 HF 住院后发生心血管 (CV) 再入院的高危个体。我们使用全国再入院数据库,检查了以 HF 为主要诊断的非致命性医院出院情况。我们根据是否存在冠状动脉疾病、心房心律失常和/或室性心律失常,计算了 0 到 3 分的心脏合并症计数。我们使用多项逻辑回归来确定心脏合并症计数是否与 CV 再入院或非 CV 再入院独立相关,同时调整了患者和医院水平的混杂因素。在 380,075 次出院中,28%的患者合并症计数为 0,47%的患者计数为 1,23%的患者计数为 2,2%的患者计数为 3。在完全调整的模型中,心脏合并症计数与 CV 再入院独立相关:与计数为 0 的个体相比,计数为 1 的个体的相对风险为 1.27(95%置信区间 [CI]:1.23 至 1.31);计数为 2 的个体的相对风险为 1.40(95% CI:1.35 至 1.46);计数为 3 的个体的相对风险为 1.36(95% CI:1.23 至 1.51)。心脏合并症计数与非 CV 再入院无关。总之,我们发现简单的心脏合并症计数与 CV 但非非 CV 再入院的风险增加独立相关。

相似文献

1
Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization.心力衰竭住院后简单心脏合并症计数与心血管再入院的关系。
Am J Cardiol. 2020 May 15;125(10):1529-1535. doi: 10.1016/j.amjcard.2020.02.018. Epub 2020 Mar 5.
2
Obstructive sleep apnea is associated with increased readmission in heart failure patients.阻塞性睡眠呼吸暂停与心力衰竭患者再入院率增加有关。
Clin Cardiol. 2017 Oct;40(10):873-878. doi: 10.1002/clc.22738. Epub 2017 Jun 6.
3
Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical center.美国一家三级医疗中心的 HIV 感染者中心力衰竭和心力衰竭不良结局。
Am Heart J. 2019 Apr;210:39-48. doi: 10.1016/j.ahj.2019.01.002. Epub 2019 Jan 11.
4
The effect of obstructive sleep apnea on readmissions and atrial fibrillation after cardiac surgery.阻塞性睡眠呼吸暂停对心脏手术后再入院和心房颤动的影响。
J Clin Anesth. 2019 Sep;56:17-23. doi: 10.1016/j.jclinane.2019.01.011. Epub 2019 Jan 18.
5
Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.心力衰竭住院后住院时间和 30 天再入院:EVEREST 试验的见解。
Eur J Heart Fail. 2015 Oct;17(10):1022-31. doi: 10.1002/ejhf.282. Epub 2015 May 9.
6
Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.慢性阻塞性肺疾病对急性心力衰竭住院后再入院的影响:一项具有全国代表性的美国队列研究。
Int J Cardiol. 2019 Sep 1;290:113-118. doi: 10.1016/j.ijcard.2019.04.087. Epub 2019 Apr 30.
7
Trends, etiologies, and predictors of 90-day readmission after percutaneous ventricular assist device implantation: A national population-based cohort study.经皮心室辅助装置植入术后90天再入院的趋势、病因及预测因素:一项基于全国人群的队列研究。
Clin Cardiol. 2018 May;41(5):561-568. doi: 10.1002/clc.22929. Epub 2018 May 10.
8
Causes and Predictors of 30-Day Readmission in Patients With Acute Myocardial Infarction and Cardiogenic Shock.急性心肌梗死合并心源性休克患者 30 天再入院的原因和预测因素。
Circ Heart Fail. 2018 Apr;11(4):e004310. doi: 10.1161/CIRCHEARTFAILURE.117.004310.
9
Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure.心力衰竭住院患者的住院时间长短与 30 天再入院和死亡率的关系。
JACC Heart Fail. 2017 Aug;5(8):578-588. doi: 10.1016/j.jchf.2017.03.012. Epub 2017 May 10.
10
Rehospitalization and resource use after inpatient admission for extracorporeal life support in the United States.美国体外生命支持住院患者再次住院和资源利用情况。
Surgery. 2019 Nov;166(5):829-834. doi: 10.1016/j.surg.2019.05.013. Epub 2019 Jul 2.

引用本文的文献

1
Suboptimal Cardiology Follow-Up Among Patients With and Without Cancer Hospitalized for Heart Failure.心力衰竭住院患者中伴有和不伴有癌症患者的心脏科随访情况不佳。
Am J Cardiol. 2023 Jun 1;196:79-86. doi: 10.1016/j.amjcard.2023.02.030. Epub 2023 Apr 4.

本文引用的文献

1
Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.加拿大和美国心力衰竭住院患者再入院率和住院时间趋势。
JAMA Cardiol. 2019 May 1;4(5):444-453. doi: 10.1001/jamacardio.2019.0766.
2
Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.老年射血分数保留或降低的心衰患者 30 天再入院的原因及时间模式。
J Am Heart Assoc. 2018 Apr 23;7(9):e007785. doi: 10.1161/JAHA.117.007785.
3
Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data: The AHRQ Elixhauser Comorbidity Index.利用医院管理数据识别再入院和住院死亡率增加的风险:AHRQ埃利克斯豪泽共病指数
Med Care. 2017 Jul;55(7):698-705. doi: 10.1097/MLR.0000000000000735.
4
Protocol for validating cardiovascular and cerebrovascular ICD-9-CM codes in healthcare administrative databases: the Umbria Data Value Project.医疗管理数据库中心血管和脑血管ICD-9-CM编码验证方案:翁布里亚数据价值项目
BMJ Open. 2017 Mar 29;7(3):e013785. doi: 10.1136/bmjopen-2016-013785.
5
Analysis of Machine Learning Techniques for Heart Failure Readmissions.心力衰竭再入院的机器学习技术分析
Circ Cardiovasc Qual Outcomes. 2016 Nov;9(6):629-640. doi: 10.1161/CIRCOUTCOMES.116.003039. Epub 2016 Nov 8.
6
Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭住院患者的特征
Am J Med. 2016 Jun;129(6):635.e15-26. doi: 10.1016/j.amjmed.2016.02.007.
7
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.射血分数降低与保留的心力衰竭患者的非心脏合并症
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93. doi: 10.1016/j.jacc.2014.08.036. Epub 2014 Nov 24.
8
The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success?心力衰竭的异质性:为使未来临床试验成功,强化表型分析是否必要?
J Am Coll Cardiol. 2014 Oct 28;64(17):1775-6. doi: 10.1016/j.jacc.2014.07.978. Epub 2014 Oct 21.
9
Clinical implications of chronic heart failure phenotypes defined by cluster analysis.通过聚类分析定义的慢性心力衰竭表型的临床意义。
J Am Coll Cardiol. 2014 Oct 28;64(17):1765-74. doi: 10.1016/j.jacc.2014.07.979. Epub 2014 Oct 21.
10
Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.心力衰竭住院期间的合并症概况及住院结局:对美国全国住院患者样本的分析
BMC Cardiovasc Disord. 2014 Jun 5;14:73. doi: 10.1186/1471-2261-14-73.